ABBOTT LABORATORIES (ABT)
Data as of , from SEC Form 4 filings.
See up to 3 months of ABT. The 7-day demo opens the 1M and 3M ranges and puts ABT on your watchlist.
Start 7-day demoLatest ABT insider trades
- John A. McCoy Jr. - OfficerOpen-market sale$3K
Robert B. Ford - OfficerOpen-market sale$25.26M
About ABBOTT LABORATORIES (ABT)
ABBOTT LABORATORIES files with the SEC under CIK 0000001800 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ABT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 404,709 | $46.85M |
| Grant or award | 5 | 1,747 | |
| Option exercise | 4 | 797,664 | |
ABT insider transactions (Form 4)
4880 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Nita Ahuja | Grant or award | Common shares without par value | 2,286 footnote F1 | $0.00 | - | |
| ||||||
| Philip P. Boudreau - Officer | Open-market purchase | Common shares without par value | 2,200 | $91.50 | $201K | |
| Philip P. Boudreau - Officer | Other | Common shares without par value | 8,909 | $92.04 | $820K | |
 John G. Stratton | Grant or award | Stock Equivalent Units | 382 | $102.67 | $39K | |
| Michael F. Roman | Grant or award | Stock Equivalent Units | 367 | $102.67 | $38K | |
 Patricia Paola Gonzalez | Grant or award | Stock Equivalent Units | 321 | $102.67 | $33K | |
| Robert J. Alpern | Grant or award | Stock Equivalent Units | 76 | $102.67 | $8K | |
| Nita Ahuja | Grant or award | Stock Equivalent Units | 102 | $102.67 | $10K | |
 Jacob A. Orville - Officer | Grant or award | Common shares without par value | 13,255 footnote F1 | $0.00 | - | |
| ||||||
| Eric Shroff - Officer | Tax withholding / forfeiture | Common shares without par value | 1,384 | $116.26 | $161K | |
| Eric Shroff - Officer | Open-market sale | Common shares without par value | 709 | $115.58 | $82K | |
 Christopher J. Scoggins - Officer | Tax withholding / forfeiture | Common shares without par value | 4,997 | $116.26 | $581K | |
| Daniel Gesua Sive Salvadori - Officer | Tax withholding / forfeiture | Common shares without par value | 6,615 | $116.26 | $769K | |
| Daniel Gesua Sive Salvadori - Officer | Open-market sale | Common shares without par value | 885 | $115.58 | $102K | |
| Louis H. Morrone - Officer | Tax withholding / forfeiture | Common shares without par value | 4,040 | $116.26 | $470K | |
| Louis H. Morrone - Officer | Open-market sale | Common shares without par value | 1,144 | $115.58 | $132K | |
 Mary K. Moreland - Officer | Tax withholding / forfeiture | Common shares without par value | 4,630 | $116.26 | $538K | |
| Mary K. Moreland - Officer | Open-market sale | Common shares without par value | 613 | $115.58 | $71K | |
| John A. McCoy Jr. - Officer | Tax withholding / forfeiture | Common shares without par value | 1,142 | $116.26 | $133K | |
| John A. McCoy Jr. - Officer | Open-market sale | Common shares without par value | 585 | $115.58 | $68K | |
| Robert B. Ford - Officer | Tax withholding / forfeiture | Common shares without par value | 30,308 | $116.26 | $3.52M | |
 Lisa D. Earnhardt - Officer | Tax withholding / forfeiture | Common shares without par value | 8,577 | $116.26 | $997K | |
| Elizabeth C. Cushman - Officer | Tax withholding / forfeiture | Common shares without par value | 1,421 | $116.26 | $165K | |
| Elizabeth C. Cushman - Officer | Open-market sale | Common shares without par value | 263 | $115.58 | $30K | |
| Philip P. Boudreau - Officer | Tax withholding / forfeiture | Common shares without par value | 7,441 | $116.26 | $865K | |
| Eric Shroff - Officer | Grant or award | Common shares without par value | 10,873 footnote F1 | $0.00 | - | |
| Eric Shroff - Officer | Grant or award | Option (right to buy) | 44,821 | $0.00 | - | |
| ||||||
| Christopher J. Scoggins - Officer | Grant or award | Common shares without par value | 18,502 footnote F1 | $0.00 | - | |
| Christopher J. Scoggins - Officer | Grant or award | Option (right to buy) | 76,273 | $0.00 | - | |
| ||||||
| Daniel Gesua Sive Salvadori - Officer | Grant or award | Common shares without par value | 21,644 footnote F1 | $0.00 | - | |
| Daniel Gesua Sive Salvadori - Officer | Grant or award | Option (right to buy) | 89,226 | $0.00 | - | |
| ||||||
| Louis H. Morrone - Officer | Grant or award | Common shares without par value | 15,418 footnote F1 | $0.00 | - | |
| Louis H. Morrone - Officer | Grant or award | Option (right to buy) | 63,561 | $0.00 | - | |
| ||||||
| Mary K. Moreland - Officer | Grant or award | Common shares without par value | 13,951 footnote F1 | $0.00 | - | |
| Mary K. Moreland - Officer | Grant or award | Option (right to buy) | 57,512 | $0.00 | - | |
| ||||||
| John A. McCoy Jr. - Officer | Grant or award | Common shares without par value | 5,373 footnote F1 | $0.00 | - | |
| John A. McCoy Jr. - Officer | Grant or award | Option (right to buy) | 22,151 | $0.00 | - | |
| ||||||
| Robert B. Ford - Officer | Grant or award | Common shares without par value | 83,464 footnote F1 | $0.00 | - | |
| Robert B. Ford - Officer | Grant or award | Option (right to buy) | 344,066 | $0.00 | - | |
| ||||||
| Lisa D. Earnhardt - Officer | Grant or award | Common shares without par value | 27,056 footnote F1 | $0.00 | - | |
| Lisa D. Earnhardt - Officer | Grant or award | Option (right to buy) | 111,533 | $0.00 | - | |
| ||||||
| Elizabeth C. Cushman - Officer | Grant or award | Common shares without par value | 15,031 footnote F1 | $0.00 | - | |
| Elizabeth C. Cushman - Officer | Grant or award | Option (right to buy) | 61,964 | $0.00 | - | |
| ||||||
| Philip P. Boudreau - Officer | Grant or award | Common shares without par value | 27,997 footnote F1 | $0.00 | - | |
| Philip P. Boudreau - Officer | Grant or award | Option (right to buy) | 115,413 | $0.00 | - | |
| ||||||
| Daniel J. Starks | Open-market purchase | Common shares without par value | 4,967 | $109.14 footnote F1 | $542K | |
| Daniel J. Starks | Open-market purchase | Common shares without par value | 5,033 | $108.33 footnote F2 | $545K | |
| ||||||
| Robert B. Ford - Officer | Open-market purchase | Common shares without par value | 18,800 | $107.13 footnote F1 | $2.01M | |
| ||||||
Item 7.01, 8.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.03, 5.07, 9.01
Item 8.01, 9.01
Recent ABT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| John A. McCoy, Jr. | Officer | 27 | $3K | View on EDGAR | |
| Robert B. Ford | Officer, Director | 398,832 | $46.20M |
Stock trades in ABT disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
ABT insider trading FAQ
What is the latest insider trade for ABT?
ABBOTT LABORATORIES (ABT) had 10 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for ABT runs to 80 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ABT stock?
No insider purchases of ABT were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling ABT stock?
4 insider sales of ABT were filed in the last 90 days, totaling $46.85M.
Where can I see ABT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ABT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John G. Stratton view on EDGAR
- - Patricia Paola Gonzalez view on EDGAR
- - Kevin T. Conroy view on EDGAR
- - Nita Ahuja view on EDGAR
- - Michael F. Roman view on EDGAR
- - Kevin T. Conroy view on EDGAR
- - John A. McCoy Jr. view on EDGAR
- - Philip P. Boudreau view on EDGAR
- - Robert B. Ford view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ABT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ABT with a 7-day demo
- ABT on your watchlist
- Every ABT Form 4 filing on record
- Up to 3 months of ABT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
